Status:

COMPLETED

A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

Lead Sponsor:

Hoffmann-La Roche

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

This study will evaluate the efficacy and safety of 2 doses of Avastin in combination with docetaxel, versus docetaxel plus placebo, in patients with metastatic HER2 negative breast cancer who are can...

Detailed Description

Five participants randomized to the docetaxel 100 mg/m\^2 plus placebo group actually received docetaxel 100 mg/m\^2 plus bevacizumab 7.5 mg/kg and are included in the docetaxel 100 mg/m\^2 plus bevac...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Female patients ≥ 18 years of age.
  • Human epidermal growth factor receptor 2 (HER2)-negative cancer of the breast with locally recurrent or metastatic disease, suitable for chemotherapy.
  • No adjuvant chemotherapy within 6 months before randomization, and no taxane-based chemotherapy within 12 months before randomization.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
  • Exclusion criteria:
  • Previous chemotherapy for metastatic or locally recurrent breast cancer.
  • Radiotherapy for treatment of metastatic disease.
  • Other primary tumors within last 5 years, except for controlled limited basal cell or squamous cancer of the skin, or cancer in situ of the cervix.
  • Spinal cord compression or brain metastases.
  • Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to randomization.
  • Inadequate bone marrow, liver, or renal function.
  • Uncontrolled hypertension.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2013

    Estimated Enrollment :

    736 Patients enrolled

    Trial Details

    Trial ID

    NCT00333775

    Start Date

    March 1 2006

    End Date

    October 1 2013

    Last Update

    January 27 2016

    Active Locations (114)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 29 (114 locations)

    1

    Adelaide, New South Wales, Australia, 5011

    2

    Camperdown, New South Wales, Australia, 2050

    3

    Westmead, New South Wales, Australia, 2145

    4

    Auchenflower, Queensland, Australia, 4066